Substance / Medication

Potassium iodide

Overview

Active Ingredient
potassium iodide
RxNorm CUI
8597

Indications

Folarex is a prescription multivitamin/multi-mineral dietary supplement formulated for the clinical dietary management of a suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed.

Labeler: Oncora Pharma, LLCUpdated: 2026-02-25T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Folarex is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Does potassium iodide application following silver diamine fluoride reduce staining of tooth? A systematic review.
Roberts A, Bradley J, Merkley S et al. · Aust Dent J · 2020
PMID: 31900927Meta-Analysis
Oral potassium iodide for the treatment of sporotrichosis.
Xue Siliang, Gu Rui, Wu Taixiang et al. · Cochrane Database Syst Rev · 2009
PMID: 19821356Meta-AnalysisFull text (PMC)
Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease.
Whalen Giles, Sullivan Mary, Maranda Louise et al. · Am J Surg · 2017
PMID: 27769543RCT
Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study.
Matsuo Yuichiro, Miyawaki Atsushi, Watanabe Hideaki et al. · J Clin Endocrinol Metab · 2025
PMID: 38546426Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Potassium iodide (substance)
SNOMED CT
89351005
UMLS CUI
C0032831
RxNorm CUI
8597
Labeler
Oncora Pharma, LLC

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

9
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.